We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
7‐Methoxy‐luteolin‐8‐C‐β‐6‐deoxy‐xylo‐pyranos‐3‐uloside exactly (mLU8C‐PU) isolated from Arthraxon hispidus inhibits migratory and invasive responses mediated via downregulation of MMP‐9 and IL‐8 expression in MCF‐7 breast cancer cells.
- Authors
Kim, Soo‐Jin; Pham, Thu‐Huyen; Bak, Yesol; Ryu, Hyung‐Won; Oh, Sei‐Ryang; Yoon, Do‐Young
- Abstract
7‐Methoxy‐luteolin‐8‐C‐β‐6‐deoxy‐xylo‐pyranos‐3‐uloside (mLU8C‐PU) is a glycosylflavone of luteolin isolated from Arthraxon hispidus (Thunb.). Luteolin is known to exert anti‐migratory and anti‐invasive effects on tumor cells. However, there are no reports on the effects of mLU8C‐PU on tumor invasiveness and associated signaling pathways. In this study, we demonstrated the anti‐migratory and anti‐invasive effects of mLU8C‐PU in 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA)‐treated MCF‐7 breast cancer cells. We also investigated the effect of mLU8C‐PU on invasion‐ related signal transducers, including protein kinase Cα (PKCα), c‐Jun N terminal kinase (JNK), activator protein‐1 (AP‐1), and nuclear factor‐kappa B (NF‐ĸB). TPA‐induced membrane translocation of PKCα, phosphorylation of JNK, and the nuclear translocations of AP‐1 and NF‐κB were downregulated by mLU8C‐PU in MCF‐7 cells. In addition, mLU8C‐PU also inhibited matrix metalloproteinase‐9 (MMP‐9) and interleukin‐8 (IL‐8) expression. These results indicate that mLU8C‐PU inhibits migratory and invasive responses in MCF‐7 breast cancer cells by suppressing MMP‐9 and IL‐8 expression through mitigating TPA‐induced PKCα, JNK activation, and the nuclear translocation of AP‐1 and NF‐κB. These results suggest that mLU8C‐PU may be used as an anti‐metastatic agent.
- Subjects
LUTEOLIN; TUMORS; CANCER cells; CANCER invasiveness; CANCER chemotherapy
- Publication
Environmental Toxicology, 2018, Vol 33, Issue 11, p1143
- ISSN
1520-4081
- Publication type
Article
- DOI
10.1002/tox.22620